8:01 am GW Pharmaceuticals receives Orphan Drug designation by FDA for Epidiolex in the treatment of Lennox-Gastaut Syndrome – HedgeChatter

8:01 am GW Pharmaceuticals receives Orphan Drug designation by FDA for Epidiolex in the treatment of Lennox-Gastaut Syndrome

03 Mar

8:01 am GW Pharmaceuticals receives Orphan Drug designation by FDA for Epidiolex in the treatment of Lennox-Gastaut Syndrome

Bystocknews GWPH, stock Comments Off

View todays social media effects on GWPH

View the latest stocks trending across Twitter. Click to view dashboard

See who GW is hiring next, click here to view

Author